High-throughput screening (HTS) is an established method in drug discovery by which hundreds of thousands of compounds are screened in an automated fashion for activity as inhibitors or activators of ...
Developing new pharmaceuticals is a complex and costly process that requires innovation and efficiency. High-throughput immunoassays (HTIs) are an emerging technology poised to accelerate the drug ...
(A) Homogenous time-resolved fluorescence (HTRF) assay screening schematic. (B) HTRF assay screening compounds. (C) HTRF assay showed that the effect of FX1, BI-3802, and YK01 blocked the interaction ...
This poster was originally authored by John Vincent, Matthew Burnham, Gerrit Daubner, and Martin Main of the Medicines Discovery Catapult. It was presented at ELRIG Drug Discovery 2023. Methods to ...
Metrion Biosciences, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Validated drug discovery assay ...
Martin Clasby receives funding from the National Institutes of Health and Michigan Drug Discovery. Modern drug discovery is an expensive and complicated process. Hundreds of scientists and at least a ...
The utilization of 3D organoids is increasingly prevalent in disease modeling and drug discovery due to their ability to better represent biologically relevant tissue architecture, microenvironments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback